2026年10月16日星期五
M
寰宇通鉴
全球快讯
[Comment] Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes— 柳叶刀 Lancet[Comment] Making every vial count: fractional dosing of yellow fever vaccine— 柳叶刀 Lancet[Comment] Shortening treatment to accelerate hepatitis C elimination— 柳叶刀 Lancet[Comment] Offline: In praise of astrologers, sorcerers, and magicians— 柳叶刀 Lancet[World Report] “You have to be willing to take risks”: the 2026 Nobel prizes— 柳叶刀 Lancet[World Report] Health in Brazil's election— 柳叶刀 Lancet[Perspectives] Shadows and interiority— 柳叶刀 Lancet[Perspectives] Beyond the battlefield: war and global health security— 柳叶刀 Lancet[Comment] Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes— 柳叶刀 Lancet[Comment] Making every vial count: fractional dosing of yellow fever vaccine— 柳叶刀 Lancet[Comment] Shortening treatment to accelerate hepatitis C elimination— 柳叶刀 Lancet[Comment] Offline: In praise of astrologers, sorcerers, and magicians— 柳叶刀 Lancet[World Report] “You have to be willing to take risks”: the 2026 Nobel prizes— 柳叶刀 Lancet[World Report] Health in Brazil's election— 柳叶刀 Lancet[Perspectives] Shadows and interiority— 柳叶刀 Lancet[Perspectives] Beyond the battlefield: war and global health security— 柳叶刀 Lancet

薄熙來前搭檔受查：重慶政壇「不倒翁」黃奇帆是誰？

来源 BBC 中文2 天前
内容摘要

中共中紀委宣佈，已退出政壇多年的前重慶市長黃奇帆涉嫌「嚴重違紀違法」，正接受調查。此消息正值中共五中全會前夕，引發外界關注。

本站仅提供标题与摘要索引，完整内容与版权均归原发布方所有，请点击原文链接阅读。

前往原文
所属频道
国际
所属地区
中国
原文语种
简体中文
条目编号
world-5dadba64

评论 0 条评论

还没有评论，来抢沙发

薄熙來前搭檔受查：重慶政壇「不倒翁」黃奇帆是誰？ · 寰宇通鉴